OUR #1 PRIORITY IS CUSTOMER HAPPINESS!

CUBENSIS BENEFITS BY THE MUSHROOM SPORE STORE

Cubensis is a Naturally Occurring Psychoactive Substance Found in So-Called Mushrooms.

While this strain of mushroom remains illegal in the U.S. and other western countries, the past decade has a seen a marked increase in medical research of this psychedelic. Medical professionals are quickly finding out that cubensis has several therapeutic applications. This is why today we are going to take a further look into this research and the many benefits that can lead cubensis to eventually become accepted as a therapeutic aid.

It is worth noting that cubensis mushrooms are illegal in the U.S. and other countries, but cubensis mushroom spores are currently legal.

WHAT IS CUBENSIS AND WHERE DOES IT COME FROM?

This is a psychedelic compound from the tryptamine grouping. Cubensis is commonly known for its existence in more than 100 species of mushroom. These species include Psilocybe cubensis, Canocybe and Paneolus, among many others.

The species highlighted above are frequently referred to as mushrooms. The is the Cubensis, which when ingested the compound has a variety of effects, such as hallucinations and awakenings. For this reason, cubensis has been used for many decades as a traditional medicine and for religious rituals.

DO CUBENSIS MUSHROOMS HAVE A LONG HISTORY OF USE AS A MEDICINE AND ENTHEOGEN?

An entheogen is a psychoactive substance used while undergoing some sort of religious, spiritual or mystical experience. It is often administered by a religious leader or experienced shaman. For these spiritual purposes, it is widely believed to have been in use for over 11,000 years.

The “Stoned Ape” theory details the possible influence cubensis has had in human evolution and development of several different cultures around the world. Let’s go into further detail regarding cubensis research below!

CUBENSIS RESEARCH IN THE 90S PAVES THE WAY FOR MODERN CLINICAL STUDIES

Following a long period with little to no research, cubensis research slowly began picking up during the mid to late 1990s. Director of Neurophsychopharmacology, Dr. Franz Vollenweider, started conducting studies with small groups to better understand the neurological mechanisms of cubensis. His work continues to explore the potential benefits cubensis offers to people with mood disorders and distress for cancer patients, as well as addiction.

Psychopharmacologist Roland Griffiths published an article in the Journal of Psychopharmacology to discuss the ability of cubensis to bring about spiritual experiences for individuals. Two thirds of his participants actually said their experience with cubensis was one of the most meaningful experiences of their lives.

Since his study in 2006, Johns Hopkins has participated in a number of newer studies featuring cubensis. Now let’s take a look at some of the benefits associated with cubensis. Most of these benefits have been uncovered in the past 10-15 years.

CUBENSIS SHOWS GREAT PROMISE AS AN EFFECTIVE TREATMENT FOR ADDICTION

During his work for Johns Hopkins, Griffiths conducted a study using cubensis on nicotine-addicted patients. After administering two to three doses of cubensis during cognitive behavioral therapy, Griffiths found that 80% of these patients were able to abstain from smoking for six months when following up.

60% of that same group was able to abstain from smoking for two and a half years during a second follow up. Traditional smoking cessation treatments generally yield a 30-40% success rate after six months.

Patients treated with cubensis were twice as likely to quit smoking following treatment. Other studies have shown that cubensis is also an effective treatment for those struggling with alcohol or cocaine addiction. Many believe this compound is a superior treatment than traditional methods used today.

CUBENSIS IMPROVES SUBJECTIVE WELL-BEING, EMPATHY, AND MAY TREAT A VARIETY OF MOOD DISORDERS

One study published in the Journal of Psychoactive Drugs shows further evidence that cubensis can offer therapeutic benefits in treating depression, anxiety and PTSD. Interestingly enough, these benefits can actually be felt up to a week after the cubensis has been ingested. Psychiatrists classify creative thinking in two categories: divergent and convergent thinking. Convergent thinking refers to a person’s ability to come up with a solution for a problem. Divergent thinking, meanwhile, refers to the ability to come up with multiple solutions to a problem.

In this study, it was found that patients given the cubensis experienced a nearly immediate improvement in convergent thinking, sometimes only a day after ingestion. These individuals noticed their convergent thinking was strengthened after just one week. So many researchers are interested in these effects because they could represent improvements in the benefits of therapy.

Cubensis benefits are thanks to the compound’s ability to manipulate the reactivity of the region of the brain responsible for mood. This could potentially represent a breakthrough in the treatment of cancer patients.

CERTAIN MUNICIPALITIES HAVE DECRIMINALIZED CUBENSIS!

It is crucial to always be careful noting the difference between decriminalization and legalization, which we discussed in an earlier article (this is very important, so if you skimmed that bit, scroll back up and read it!). The three municipalities in the Untied States which have decriminalized cubensis are as follows:

  • DENVER, COLORADO
  • OAKLAND, CALIFORNIA
  • SANTA CRUZ, CALIFORNIA

CUBENSIS MAY HELP ADVANCED-STAGE CANCER PATIENTS TREAT DEPRESSION, ANXIETY, AND GENERAL DISTRESS

Studies have shown that cubensis could potentially improve the mood and overall well-being of advanced-stage cancer patients. These patients are understandably prone to anxiety, distress and depression. In some cases, these symptoms can exacerbate their existing conditions.

Randomized, double-blind studies have shown that low doses of cubensis can improve mood disorders in relevant ways. In one study, a total of 51 patients were given cubensis. Researchers followed up with the participants six months later. What they found was 80% of the participants were experiencing reduced anxiety and depression. Cubensis proponents are very hopeful that this growing body of work will result in reformed opinions regarding this psychedelic.

INTERESTED IN STUDYING CUBENSIS MUSHROOM SPORES? HERE’S HOW TO START

While growing cubensis mushrooms is illegal, amateur microscopists still enjoy studying cubensis spores. Since spores don’t contain cubensis or psilocin, they are legal in the majority of the U.S. Before starting your very own amateur microscopy or spore taxonomy adventure, we recommend reading our page Mushroom Spores & Microscopy Research.

NEED HELP?

CONTACT US HERE